40 mg/0.4mL
Trade Name
Nucala
Solution for Injection
Request Type
Registration
Drug Type
Biological Drug
Approval Date
SFDA Approved Use
Mepolizumab is indicated for the add-on maintenance treatment of adult and pediatric patients aged 6 years and older with severe asthma and with an eosinophilic phenotype